from INCEPTION to EXIT
INCEPTION
WALTER GREENBLATT & ASSOCIATES enables scientist-entrepreneurs to raise the seed capital to lock down key intellectual property, generate compelling proof-of-concept data and form a company
Learn More
DEVELOPMENT
WALTER GREENBLATT & ASSOCIATES helps entrepreneurs advance their products towards regulatory approval and the market
Learn More
GROWTH
WALTER GREENBLATT & ASSOCIATES enables companies to raise the early stage capital to demonstrate and build clinical and commercial traction
Learn More
EXIT
WALTER GREENBLATT & ASSOCIATES helps biotech owners position their companies for exits that maximize value
Image: WGA Client WuXi Pharmatech IPO (NYSE:WX) on August 9, 2007 at $1.1 billion valuation
Learn More
